MoonBio (Moon Guangzhou Biotech)
慕恩（广州）生物科技有限公司
Guangzhou's strongest pilot-fermentation lead — a microbial-resource-and-biomanufacturing platform selected onto China's first national biomanufacturing pilot-platform list, with a very large proprietary strain library and a full-chain discovery-to-scale-up process.
- Location
- Huangpu District, Science City (Guangzhou High-tech Zone) · Guangzhou
- Visit window
- Day-trip from Shenzhen · Weeks 2–4
- Source status
- high confidenceprofiled
Next action
Prepare the private outreach route and meeting ask; keep contact details out of the app.
Why now: Visit window · Day-trip from Shenzhen · Weeks 2–4
What they do
Founded 2016, MoonBio commercialises microbiome resources via its DREAM platform: biodiversity access, high-throughput screening, fermentation optimisation and formulation. Application areas span bio-agriculture, microbial protein, biomedicine/live-bacteria drugs and food/additives, and it was selected into the first national batch of biomanufacturing pilot platforms.
It also runs a published fee-for-service (commissioned) business including strain isolation/identification, bio-synthesis and microbial testing (explicitly accepting cosmetic-sample microbial testing).
Why it matters
High on the lead priority: bio-agriculture is an explicit MoonBio application area, so its very large proprietary strain library and discovery-to-scale-up chain map directly onto Pure Advance's AI-accelerated microbial-biocontrol and resource-discovery core, with a national-listed pilot platform that may run external batches. Secondary angle: the same library could screen microbes and postbiotics for skin-barrier or anti-irritation effects for the Coolvex line.
Visit objective & route
Assess external pilot/scale-up fermentation capacity and downstream processing, plus library screening for skin-barrier / anti-irritation / postbiotic actives, and clarify the IP model — serving both the lead biocontrol platform and the secondary Coolvex line.
Approach route
Direct published BD channel (an InnoX/program intro is helpful but not required); plan a dedicated Guangzhou day-trip from Shenzhen.
Talking points
- Can you screen microbes, metabolites or postbiotics for skin-barrier or anti-irritation effects?
- What external pilot-scale fermentation capacity and downstream processing do you offer?
- Any cosmetic/dermatology ingredient experience, and what is the IP model for discovered strains?
- Is a Guangzhou day-trip visit possible during the program?
- Bring: Pure Advance one-pager, screening-targets brief and NDA template.
Open questions
- Do they accept external pilot fermentation / CDMO projects, and at what working volumes (5 L to 1000 L+)?
- Any cosmetic/dermatology/topical ingredient experience, or only food/agri/biomed?
- Downstream processing and quality documentation (COA, INCI/CAS, stability) for topical use.
- IP model for discovered strains/metabolites.
- Reconcile the reported strain-library count (~230k vs ~340k) and 2015/2016 founding date; export to KSA/GCC.
- Confirm a BD contact channel and exact metro access before travel.
Risks & unknowns
- Public service field skews food/additives/agriculture rather than dermatology/cosmetics — topical-active track record not yet evidenced.
- External pilot/industrial fermentation volumes, terms and GMP grade are unconfirmed.
- Requires a dedicated Guangzhou day-trip from Shenzhen.
- No GCC/Saudi/halal/export signal found.
Private-pack boundary